The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment
{{output}}
Background and aim: Although there are case reports and guideline recommendations that states omalizumab can be used in chronic spontaneous urticaria (CSU) patients during SARS-CoV-2 pandemic, there are scarce studies showing the... ...
